To Newsroom
Oriola-KD's fully owned subsidiary Medstop AB will exercise the option to call the SEK 700 million bonds
3.6.2013
Oriola-KD Corporation Stock Exchange Release 3 June 2013 at 1.05 p.m In connection with the completion of the Medstop acquisition Oriola-KD's fully owned subsidiary Medstop AB will exercise the option to call all of the outstanding SEK 700 million bonds (ISIN SE0003961655). The bonds will be called pursuant to ยง 7 of the Terms and Conditions where Medstop will exercise its right to call the bonds at 102.75 per cent of the Nominal Amount plus accrued interest. The redemption date of the bonds is 2 July 2013 and one must be a bondholder on 25 June 2013 to have a right to the payment. The bonds will cease to trade on 19 June 2013 and as part of the early redemption process the bonds will also be de-listed from the Frankfurt Stock Exchange. The redemption of the bonds will be financed by existing credit facilities. Oriola-KD Corporation Oriola-KD Corporation Tuomas Itkonen CFO Joni Ihantola Vice President, Treasury and IR For further information, please contact: Tuomas Itkonen CFO Tel. +358 (0)46 876 5207 e-mail: tuomas.itkonen@oriola-kd.com Joni Ihantola Vice President, Treasury and IR tel. +358 (0)10 429 4386 email: joni.ihantola@oriola-kd.com Distribution: NASDAQ OMX Helsinki Ltd. Key media Released by: Oriola-KD Corporation Corporate Communications Orionintie 5 FI-02200 Espoo www.oriola-kd.com [HUG#1706581]
